2022 China New Design Gentamicin Sulfate 0.3 - dexamethasone sodium phosphate injection – Xinanran
2022 China New Design Gentamicin Sulfate 0.3 - dexamethasone sodium phosphate injection – Xinanran Detail:
[ Adverse reaction ] (1) There were strong water and sodium retention and potassium excretion.
(2) Has strong immunosuppressive effect.
(3) High dose use in late pregnancy might cause abortion.
[ Notice ] (1) It is contra-indicated in pregnant animals at earlier or late stages.
(2) In case of bacterial infections it should be combined with antimicrobial agents.
(3) Long-term medication should not be discontinued suddenly, the dosage gradually reduced until discontinuation.
[Withdrawal period] Cattle, sheep and pigs 21 days; The milk abandonment period is 72 hours.
[ Specification ] (1) 1ml:1mg (2) 5ml:5mg
[Storage] Shading the light and keeping it in a closed manner.
[Period of validity] Two years
[Manufacturing enterprise ] Hebei XinAnRan Biotechnology Co., Ltd
[Factory address] No. 6 First Row East, Konggang Street Economic Development Zone, Xinle City, Hebei Province.
Product detail pictures:
Related Product Guide:
Innovation, excellent and reliability are the core values of our business. These principles today extra than ever form the basis of our success as an internationally active mid-size company for 2022 China New Design Gentamicin Sulfate 0.3 - dexamethasone sodium phosphate injection – Xinanran , The product will supply to all over the world, such as: United States, kazan, Sweden, We have a excellent team supplying professional service, prompt reply, timely delivery, excellent quality and best price to our customers. Satisfaction and good credit to every customer is our priority. We are sincerely looking forward to cooperate with customers all over the world. We believe we can satisfy with you. We also warmly welcome customers to visit our company and purchase our products.
By Beulah from Azerbaijan - 2017.06.22 12:49
Managers are visionary, they have the idea of "mutual benefits, continuous improvement and innovation", we have a pleasant conversation and Cooperation.
By Klemen Hrovat from France - 2018.11.02 11:11